About Verge Genomics
Verge Genomics is a company based in San Francisco (United States) founded in 2015 by Jason Chen.. Verge Genomics has raised $134.5 million across 4 funding rounds from investors including Lilly, WuXi AppTec and BlackRock. The company has 38 employees as of December 31, 2024. Verge Genomics offers products and services including CONVERGE Platform and VRG50635. Verge Genomics operates in a competitive market with competitors including Biogen, Insitro, BridgeBio, ATAI and Denali Therapeutics, among others.
- Headquarter San Francisco, United States
- Employees 38 as on 31 Dec, 2024
- Founders Jason Chen
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Verge Analytics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$134.5 M (USD)
in 4 rounds
-
Latest Funding Round
$98 M (USD), Series B
Dec 16, 2021
-
Investors
Lilly
& 21 more
-
Employee Count
38
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Verge Genomics
Verge Genomics offers a comprehensive portfolio of products and services, including CONVERGE Platform and VRG50635. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI system for mapping disease causes and developing drug candidates.
Small molecule inhibitor targeting ALS and other neurological conditions.
Unlock access to complete
Unlock access to complete
Funding Insights of Verge Genomics
Verge Genomics has successfully raised a total of $134.5M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $98 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $98.0M
-
First Round
First Round
(21 Jul 2015)
- Investors Count 22
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Series B - Verge Genomics | Valuation | BlackRock | |
| Jul, 2018 | Amount | Series A - Verge Genomics | Valuation | DFJ , WuXi AppTec |
|
| Nov, 2015 | Amount | Seed - Verge Genomics | Valuation | IA Ventures , Two Sigma Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Verge Genomics
Verge Genomics has secured backing from 22 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Lilly, WuXi AppTec and BlackRock. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate-backed venture capital is focused on the life science sector.
|
Founded Year | Domain | Location | |
|
A venture capital fund focused on biotech for neurodegeneration.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Verge Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Verge Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Verge Genomics Comparisons
Competitors of Verge Genomics
Verge Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, Insitro, BridgeBio, ATAI and Denali Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Cloud-based genome informatics and data management are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Verge Genomics
Frequently Asked Questions about Verge Genomics
When was Verge Genomics founded?
Verge Genomics was founded in 2015.
Where is Verge Genomics located?
Verge Genomics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Verge Genomics a funded company?
Verge Genomics is a funded company, having raised a total of $134.5M across 4 funding rounds to date. The company's 1st funding round was a Seed of $4M, raised on Jul 21, 2015.
How many employees does Verge Genomics have?
As of Dec 31, 2024, the latest employee count at Verge Genomics is 38.
What does Verge Genomics do?
Verge Genomics was founded in 2015 in San Francisco, United States, within the biotechnology sector. Therapeutics for neurodegenerative diseases are developed through computational genomics, leveraging proprietary datasets from human samples. Disease-causing genes are mapped, and drugs are identified to target multiple genes concurrently. Conditions addressed include amyotrophic lateral sclerosis, Parkinsons disease, and frontotemporal dementia. Network algorithms are applied to genomic data to support this process.
Who are the top competitors of Verge Genomics?
Verge Genomics's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Verge Genomics offer?
Verge Genomics offers CONVERGE Platform and VRG50635.
Who are Verge Genomics's investors?
Verge Genomics has 22 investors. Key investors include Lilly, WuXi AppTec, BlackRock, Merck Global Health Innovation Fund, and Vulcan Aerospace.